Martin SJ - Search Results

1

Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections.

MacLaren R, Bond CA, Martin SJ, Fike D. MacLaren R, et al. Among authors: martin sj. Crit Care Med. 2008 Dec;36(12):3184-9. doi: 10.1097/CCM.0b013e31818f2269. Crit Care Med. 2008. PMID: 18936700

2

Critical care pharmacy services in United States hospitals.

Maclaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA. Maclaren R, et al. Among authors: martin sj. Ann Pharmacother. 2006 Apr;40(4):612-8. doi: 10.1345/aph.1G590. Epub 2006 Mar 28. Ann Pharmacother. 2006. PMID: 16569803

3

Intravenous to oral conversion of antihypertensives: a toolkit for guideline development.

Dasta JF, Boucher BA, Brophy GM, Cohen H, Hassan E, Maclaren R, Muzykovsky K, Martin SJ, Pass SE, Seybert AL. Dasta JF, et al. Among authors: martin sj. Ann Pharmacother. 2010 Sep;44(9):1430-47. doi: 10.1345/aph.1P086. Epub 2010 Aug 11. Ann Pharmacother. 2010. PMID: 20702758 Review.

4

Infectious diseases in the critically ill patients.

Martin SJ, Yost RJ. Martin SJ, et al. J Pharm Pract. 2011 Feb;24(1):35-43. doi: 10.1177/0897190010388906. J Pharm Pract. 2011. PMID: 21507873 Review.

5

Continuous infusion of loop diuretics in the critically ill: a review of the literature.

Martin SJ, Danziger LH. Martin SJ, et al. Crit Care Med. 1994 Aug;22(8):1323-9. doi: 10.1097/00003246-199408000-00017. Crit Care Med. 1994. PMID: 8045153 Review.

6

Key articles and guidelines relative to intensive care unit pharmacotherapy: 2009 update.

Erstad BL, Brophy GM, Martin SJ, Haas CE, Devlin JW, Welage LS, Dager WE. Erstad BL, et al. Among authors: martin sj. Pharmacotherapy. 2009 Oct;29(10):1228-69. doi: 10.1592/phco.29.10.1228. Pharmacotherapy. 2009. PMID: 19792995 Free article.

7

Key articles and guidelines relative to intensive care unit pharmacology--2004.

Erstad BL, Martin SJ, Brophy GM, Haas CE, Jacobi J, Welage LS, Thomas MC. Erstad BL, et al. Among authors: martin sj. Pharmacotherapy. 2005 Apr;25(4):585-610. doi: 10.1592/phco.25.4.585.61024. Pharmacotherapy. 2005. PMID: 15977919 Free article.

8

Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections.

Martin SJ, Sahloff EG, Close SJ. Martin SJ, et al. Expert Opin Pharmacother. 2002 Sep;3(9):1251-66. doi: 10.1517/14656566.3.9.1251. Expert Opin Pharmacother. 2002. PMID: 12186618 Review.

9

Effect of perfluorooctyl bromide on bacterial growth.

Jung R, Pendland SL, Martin SJ. Jung R, et al. Among authors: martin sj. Chemotherapy. 2003 May;49(1-2):1-7. doi: 10.1159/000069772. Chemotherapy. 2003. PMID: 12714802

10

Combined bactericidal activity of perfluorooctyl bromide and aminoglycosides against Pseudomonas aeruginosa.

Jung R, Pendland SL, Martin SJ. Jung R, et al. Among authors: martin sj. J Antimicrob Chemother. 2002 Dec;50(6):939-44. doi: 10.1093/jac/dkf226. J Antimicrob Chemother. 2002. PMID: 12461015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters